Global Oncology Drugs Market to Cross USD 763 Billion by 2035: Report
The growth of the oncology drugs market is driven by rising cancer prevalence, advancements in targeted therapies and immunotherapy, and the expansion of precision medicine.
The growth of the oncology drugs market is driven by rising cancer prevalence, advancements in targeted therapies and immunotherapy, and the expansion of precision medicine.
Under the agreement, AstraZeneca has acquired worldwide rights to develop and commercialise Zegfrovy.
Johnson & Johnson’s MONARCH Platform helps improve early lung cancer detection by enabling physicians to access and biopsy suspicious lung nodules that are difficult to reach with conventional bronchoscopy.
WHO calls for placing people affected by cancer at the centre of cancer control efforts